生物活性 | |||
---|---|---|---|
描述 | Nirogacestat (PF-3084014) functions as an orally available, reversible, non-competitive, and selective inhibitor of γ-secretase, demonstrating an IC50 of 6.2 nM. Its ability to suppress Notch signaling effectively while reducing the risk of gastrointestinal side effects makes it a valuable candidate for the exploration of cancers dependent on Notch receptor activity[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.04mL 0.41mL 0.20mL |
10.21mL 2.04mL 1.02mL |
20.42mL 4.08mL 2.04mL |
参考文献 |
---|